Mcnulty Korea Co., Ltd. announced that it expects to receive KRW 5 billion in funding
January 31, 2019
Share
Mcnulty Korea Co., Ltd. (KOSDAQ:A222980) announced a private placement of round 1 unregistered coupon unguaranteed private convertible bond for gross proceeds of KRW 5,000,000,000 on January 31, 2019. The coupon rate and yield to maturity is 0%. The maturity date of bonds is February 8, 2024. The bonds are 100% convertible into 390,625 common shares of the company at a conversion price of KRW 12,800 per share, representing 7.85% stake in the company from February 8, 2020 to January 8, 2024. The payment date is February 8, 2019. The transaction has been approved by the board of directors of the company. The transaction will include participation from new investors SP Mezzanine Private Investment Trust 2 for KRW 1,000,000,000; SP KOSDAQ Venture Private Investment Trust 1 for KRW 1,000,000,000; JC Asset KOSDAQ Venture Hedge Fund 1 for KRW 800,000,000; JC Asset KOSDAQ Venture Hedge Fund 2 for KRW 300,000,000; JC Asset KOSDAQ Venture Hedge Fund 3 for KRW 200,000,000; and JC Asset KOSDAQ Venture Hedge Fund 5 for 1,700,000,000.
Mcnulty Korea Co., Ltd. is a Korea-based company mainly engaged in the manufacture of coffees. The Company purchases green beans of coffee and produces coffees of different types by roasting. The Company's product portfolio consists of roasted coffees including whole beans, crushed beans, triangular tea bags, square tea bags and hand drips, instant coffees including coffee mixes and instant bean coffees and coffee beverages including portion coffees and ice coffees. The Company also manufactures ethical (ETC) drugs including painkillers, diabetes diagnosis drugs and colonic irrigation drugs and over the counter (OTC) drugs including cold medicines, hair restorers and cold medicines for children.
MCNULTY KOREA CO., LTD. 
